The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

✍ Scribed by Pascal Guerard; Zo Rakotoniaina; Françoise Goirand; Luc Rochette; Monique Dumas; Frederic Lirussi; Marc Bardou

• Publisher: Springer-Verlag
• Year: 2006
• Tongue: English
• Weight: 640 KB
• Volume: 373
• Category: Article
• ISSN: 0028-1298
• DOI: 10.1007/s00210-006-0082-1